SEARCH

SEARCH BY CITATION

References

  • 1
    Engel J, Bork A, Nubert I, Schoenberger H. Synthese von 14C-Anpirtolin. Arch Pharma Weinheim 1988; 321: 821822.
  • 2
    Schlicker E, Werner U, Hamon M, Gozlan H, Nickel B, Szelenyi I, Göthert M. Anpirtoline, a novel, highly potent 5HT1b receptor agonist with antinociceptive/antidepressant-like actions in rodents. Br J Pharmac 1992; 105: 732738.
  • 3
    Engel J, Scheffler G, Nickel B, Thiemer K, Tibes U, Werner U, Szeleny I. Anpirtoline hydrochloride. Drugs Future 1989; 14: 614619.
  • 4
    Swedberg MDB, Shannon HE, Nickel B, Goldberg SR. D-16949 (anpirtoline): a novel serotonergic (5-HT1B) psychotherapeutic agent assessed by its discriminative effects in the rat. J Pharmac exp Ther 1992; 263: 10151022.
  • 5
    Zemlan FB, Behbenhani MM, Murphy RM. Serotonin receptor subtypes and the modulation of pain transmission. Progr Brain Res 1988; 77: 349355.
  • 6
    Swaynok J. The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies. Can J Physiol Pharmac 1989; 67: 975988.
  • 7
    Roberts MHT. Involvement of serotonin in nociceptive pathways. Drug Des Deliv 1989; 4: 7783.
  • 8
    Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Ann Rev Neurosci 1991; 14: 210245.
  • 9
    Kobal G. Pain-related electrical potentials of the human mucosa elicited by chemical stimulation. Pain 1985; 22: 151163.
  • 10
    Regan D. Human brain electrophysiology. New York: Elsevier, 1989; 280.
  • 11
    Steen KH, Reeh PW, Anton F, Handwerker H-O. Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro. J Neurosci 1992; 12: 8695.
  • 12
    Thürauf N, Friedel I, Hummel C, Kobal G. The mucosal potential elicited by noxious chemical stimuli: is it a peripheral nociceptive event. Neurosci Lett 1991; 128: 297300.
  • 13
    Anton F, Euchner I, Handwerker H-O. Psychophysical examination of pain induced by defined CO2 pulses applied to the nasal mucosa. Pain 1992; 49: 5360.
  • 14
    Picton TW, Hillyard SA. Endogenous event-related potentials. In EEG-Handbook (revised series, Vol. 3), ed Picton TW, Amsterdam: Elsevier, 1988; 361426.
  • 15
    Kobal G, Hummel T. Brain responses to chemical stimulation of trigeminal nerve in man. In Chemical Senses, Vol. 2: Irritation, eds Green BG, Mason JR, Kare MR, New York: Marcel-Dekker, 1989; 123129.
  • 16
    Huttunen J, Kobal G, Kaukoronta E, Hari R. Cortical responses to painful CO2-stimulation of nasal mucosa: A magnetencephalographic study in man. Electroenceph clin Neurophysiol 1986; 64: 347349.
  • 17
    Chudler EH, Dong WK, Kawakami Y. Tooth pulp evoked potentials in the monkey: Cortical surface and intracortical distribution. Pain 1985; 22: 221223.
  • 18
    Kobal G, Hummel T, Hoesl M. Pain-related electrical evoked potentials by chemical stimuli: Effects of Fentanyl. In Advances in Pain Research and Therapy Vol. 12, eds Lipton S, Tunks E, Zoppi M, New York: Raven Press, 1989; 9598.
  • 19
    Kobal G, Hummel C, Nürnberg B, Brune K. Effects of Pentazocine and Acetylsalicylic Acid on Pain-rating, Pain-related Evoked Potentials and Vigilance in Relationship to Pharmacokinetic Parameters. Agents Actions 1990; 29: 342359.
  • 20
    Hummel T, Friedman T, Pauli E, Niebch G, Borbe HO, Kobal G. Dose-related analgesic effects of flupirtine. Br J clin Pharmac 1991; 32: 6977.
  • 21
    Alon E, Schulthess G, Axhausen C, Hossli G. ***Doppel-blindvergleichsstudie über die Wirkung von Tramadol und Buprenorphine auf die postoperativen Schmerzen. Anaesthesist 1981; 30: 623626.
  • 22
    Bromm B, Hermann WM, Scharein, E. Zwei effektive Analgetika im Wirkungsvergleich. Fortschr Med 1989; 107: 385389.
  • 23
    Bernatzky G, Jurna I. Intrathecal injection of codeine, buprenorphine, tilidine, tramadol and nefopam depresses the tail-flick response in rats. Eur J Pharmac 1986; 120: 7580.
  • 24
    Hennies H-H, Friderichs E, Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Drug Res 1988; 38: 877880.
  • 25
    Rohdewald P, Granitzki HW, Neddermann E. Comparison of the analgesic efficacy of metamizole and tramadol in experimental pain. Pharmacology 1988; 37: 209217.
  • 26
    Vogel W, Burchardi H, Sihler K, Valic L. Über die Wirkung von Tramadol auf Atmung und Kreislauf. Drug Res 1978; 28: 183186.
  • 27
    Flohe L, Arend I, Cogal A, Richter W, Simon W. Klinische Prüfung der Abhängigkeitsentwicklung nach Langzeitapplikation von Tramadol. Drug Res 1978; 28: 213217.
  • 28
    Richter W, Barth H, Flohe L, Giertz H. Klinische Untersuchung zur Abhängigkeitsentwicklung bei oraler Therapie mit Tramadol. Drug Res 1985; 35: 17421744.
  • 29
    Magni G. The use of antidepressants in the treatment of chronic pain. Drugs 1991; 42: 730748.
  • 30
    France RD, Houpt JL, Ellinwood EH. Therapeutic effects of antidepressants in chronic pain. Gen Hosp Psychiatry 1984; 6: 5563.
  • 31
    Walsh TD. Antidepressants in chronic pain. Clin Neuropharmac 1983; 6: 271295.
  • 32
    Bromm B, Meier W, Scharein E. Imipramine reduces experimental pain. Pain 1986; 25: 245257.
  • 33
    Ardid D, Eschalier A, Lavarenne J. Evidence for a central but not a peripheral analgesic effect of clomipramine in rats. Pain 1991; 45: 95100.
  • 34
    Eide K, Hole K. Acute and chronic treatment with selective serotonin uptake inhibitors in mice: effects on nociceptive sensitivity and response to 5-methoxy-N, N-dimethyltryptamine. Pain 1988; 32: 333340.
  • 35
    Fialip RG, Makambila MC, Rigal F, Devoize JL, Varoquax O, Eschalier A. Chronic administration of clomipramine inhibits morphine hot-plate analgesia. Life Sci 1986; 38: 10971103.
  • 36
    Sacerdote P, Brini A, Mantegazza P, Panerai AE. A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmac Biochem Behav 1987; 26: 153158.
  • 37
    Lintz W, Barth H, Osterloh G, Schmidt-Bothelt E. Bioavailability of enteral tramadol formulations. 1st communication: capsules. Arzneimittelforschung 1986; 36: 12781283.
  • 38
    ASTA-Pharma AG, Frankfurt, FRG. Investigational drug brochure, D16949 Anpirtoline, 1989.
  • 39
    Suttfin TA, De Vance CL, Jusko WJ. The analysis and disposition of imipramine and its active metabolites in man. Psychopharmacologia (Berlin) 1984; 82: 310317.
  • 40
    Becker DE, Yingling CD, Fein G. Identification of pain, intensity and P300 components in the pain evoked potential. Electroenceph clin Neurophysiol 1993; 88: 290301.
  • 41
    Reading EA. Testing pain mechanisms in persons in pain. In Textbook of pain, eds Wall PD, Melzack R, Edinburgh: Churchill Livingstone, 1989; 269280.
  • 42
    Bundesgesundheitsamt. Katalog unerwünschter Arzneimittelwirkungen (UAW) einschließlich der deutschen Übersetzung der WHO-Adverse Reaction Terminology, Version 1.0. Bundesgesundheitsamt, 14171 Berlin, 1988.
  • 43
    Klose R, Erhart A, Jung R. Der Einfluß von Buprenorphin und Tramadol auf die CO2-Antwort in der postoperativen Phase nach Allgemeinanästhesie. Anästh Intensivther Notfallmed 1982; 17: 2934.
  • 44
    Lehmann KA, Jung C, Ribbert N, Van Heis R, Daub D. Postoperative “On-Demand”-Analgesie: eine vergleichende Untersuchung mit 5 Schmerzmitteln. Anaesthetist 1983; 32: 162163.
  • 45
    Friedel B. Die Wirkung von Tramadol auf das Elektroenzephalogramm und Elektronystagmogramm. Drug Res 1978; 28: 187189.
  • 46
    Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In The pharmacological basis of therapeutics, eds Gilman AG, Goodman LS, Rall TW, Murad F, New York: Macmillan, 1985; 387445.
  • 47
    Weisenberg M. Cognitive aspects of pain. In Textbook of pain, eds Wall PD, Melzack R, Edinburgh: Churchill Livingstone, 1989; 231241.
  • 48
    Craig KD. Emotional aspects of pain. In Textbook of pain, eds Wall PD, Melzack R, Edinburgh: Churchill Livingstone, 1989; 220230.
  • 49
    Kobal G, Hummel T. Effects of flupirtine on the pain-related evoked potential and the spontaneous EEG. Agents Actions 1988; 23: 117119.
  • 50
    Hoesl M. Beeinflußung schmerzkorrelierter evozierter Potentiale durch Analgetika und Benzodiazepine. Medical Thesis University of Erlangen-Nürnberg, Germany, 1989.
  • 51
    Bromm B, Meier W. The intracutaneous stimulus: A new pain model for algesimetric studies. Meth find exp clin Pharmac 1984; 6: 405410.
  • 52
    Gracely RH. Methods of testing pain mechanisms in normal man. In Textbook of pain, eds Wall PD, Melzack R, Edinburgh: Churchill Livingstone, 1989; 257268.
  • 53
    Dong WK, Chudler EH, Martin RH. Physiological properties of intradental mechanoreceptors. Brain Res 1985; 334: 389395.
  • 54
    Sessle BJ. Is the tooth pulp a ‘pure’ source of noxious input? In Advances in pain research and therapy, Vol. 3, eds Bonica JJ, Liebeskind JC, Albe-Fessard DG, New York: Raven Press. 1979; 245260.